Smith & Nephew plc (NYSE:SNN) Short Interest Down 23.3% in January

Smith & Nephew plc (NYSE:SNN) was the recipient of a significant decrease in short interest in the month of January. As of January 15th, there was short interest totalling 2,140,000 shares, a decrease of 23.3% from the December 31st total of 2,790,000 shares. Based on an average daily volume of 904,700 shares, the short-interest ratio is presently 2.4 days. Currently, 0.5% of the company’s stock are sold short.

Smith & Nephew Trading Down 1.1 %

Shares of SNN traded down $0.28 during midday trading on Friday, hitting $25.38. 389,828 shares of the company traded hands, compared to its average volume of 813,341. Smith & Nephew has a one year low of $23.65 and a one year high of $31.72. The company has a current ratio of 2.51, a quick ratio of 1.11 and a debt-to-equity ratio of 0.63. The stock has a 50-day moving average of $25.05 and a 200-day moving average of $27.64.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the company. Lorne Steinberg Wealth Management Inc. increased its holdings in shares of Smith & Nephew by 0.9% in the 4th quarter. Lorne Steinberg Wealth Management Inc. now owns 233,155 shares of the medical equipment provider’s stock worth $5,731,000 after buying an additional 2,160 shares during the last quarter. Hara Capital LLC boosted its holdings in Smith & Nephew by 391.4% during the 4th quarter. Hara Capital LLC now owns 2,457 shares of the medical equipment provider’s stock valued at $60,000 after acquiring an additional 1,957 shares during the period. Sanctuary Advisors LLC grew its holdings in shares of Smith & Nephew by 7.8% in the fourth quarter. Sanctuary Advisors LLC now owns 24,904 shares of the medical equipment provider’s stock worth $639,000 after purchasing an additional 1,810 shares during the last quarter. Principal Securities Inc. increased its position in shares of Smith & Nephew by 87.6% in the fourth quarter. Principal Securities Inc. now owns 1,480 shares of the medical equipment provider’s stock valued at $36,000 after acquiring an additional 691 shares during the period. Finally, ABC Arbitrage SA bought a new position in Smith & Nephew during the 4th quarter valued at approximately $4,847,000. Institutional investors own 25.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the stock. Deutsche Bank Aktiengesellschaft lowered shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research note on Friday, November 1st. Berenberg Bank lowered shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research report on Wednesday, November 6th. Finally, StockNews.com cut Smith & Nephew from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, November 12th.

Smith & Nephew Company Profile

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.